Agenus
AGEN
#9021
Rank
A$0.16 B
Marketcap
A$4.63
Share price
-1.78%
Change (1 day)
35.24%
Change (1 year)

Earnings for Agenus (AGEN)

Earnings in 2025 (TTM): A$27.43 Million

According to Agenus 's latest financial reports the company's current earnings are A$0.10 Billion. In 2024 the company made an earning of -A$0.17 Billion, an increase over its 2023 earnings that were of -A$0.23 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Agenus from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$27.43 M-117.11%
2024 -A$0.17 Billion-28.13%
2023 -A$0.23 Billion-5.5%
2022 -A$0.24 Billion-556.26%
2021 A$51.75 M-130.37%
2020 -A$0.18 Billion73.75%
2019 -A$98.08 Million-48.74%
2018 -A$0.2 Billion34.32%
2017 -A$0.15 Billion-7.16%
2016 -A$0.16 Billion26.55%
2015 -A$0.13 Billion110.24%
2014 -A$57.67 Million49.12%
2013 -A$38.68 Million
2011 -A$26.71 Million-12.25%
2010 -A$30.43 Million-21.41%
2009 -A$38.72 Million-26.86%
2008 -A$52.94 Million13.72%
2007 -A$46.56 Million-33.4%
2006 -A$69.91 Million-31.84%
2005 -A$0.11 Billion9.74%
2004 -A$93.45 Million-0.8%
2003 -A$94.21 Million17.37%
2002 -A$80.27 Million37.83%
2001 -A$58.24 Million55.99%
2000 -A$37.34 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$45.31 B 156,682.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$32.30 B 111,645.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$11.23 B 38,776.25%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$13.04 B 45,018.81%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
-A$0.36 Billion-1,340.09%๐Ÿ‡บ๐Ÿ‡ธ USA